Trends in Asthma-Rhinitis Allergic Multimorbidity and Polysensitization in China: The CARRAD Study

Abstract

The trends in allergic comorbidities secondary to the environmental variations in China remain unclear. We aimed to determine the variation of allergic comorbidities and polysensitization among asthma and/or rhinitis patients in the past decade. We assessed two nationally representative cross-sectional datasets from 2008 to 2009 and 2018 to 2019, which enrolled 2322 and 2353 patients, respectively. Over the present 10-year study period, the prevalence of allergic symptoms and allergen sensitivity among patients with multiple sensitivities in the 2018–2019 cohort was significantly higher than that in the 2008–2009 cohort, especially for mites, pollen, and animal allergens. The comorbidity rates of asthma, allergic rhinitis, conjunctivitis, and eczema were significantly increased in the 2018–2019 cohort. Also in that cohort, IgE polysensitization was significantly associated with the coexistence of asthma and rhinitis, and the number of IgE-reactive allergens was significantly associated with the number of multimorbidities. Use of an air-conditioner and carpet in the home, and keeping pet were linked to the risk of polysensitization. Our findings suggest an increase in the comorbidity rate and multimorbid polysensitized phenotype of allergic diseases in China. Asthma occurred in both cohorts more frequently with coexisting allergies than as a single entity.

Keywords

allergic comorbidities / allergic rhinitis / asthma / epidemiology / polysensitization

References

[1] W. Wang, J. Wang, G. Song, et al., “Environmental and Sensitization Variations Among Asthma and/or Rhinitis Patients Between 2008 and 2018 in China,” Clinical and Translational Allergy 12, no. 2 (2022): e12116, 1–14.

[2] W. Wang, J. Wang, Y. Jiang, et al., “A 10-Year Comparative Study of Factors for Allergic Asthma and/or Rhinitis in Two Cross-Sectional Surveys,” Asian Pacific Journal of Allergy and Immunology 44 (2026): 131–143.

[3] A. Cardenas, R. Fadadu, and S. Bunyavanich, “Climate Change and Epigenetic Biomarkers in Allergic and Airway Diseases,” Journal of Allergy and Clinical Immunology 152, no. 5 (2023): 1060–1072.

[4] Y. T. Li, M. H. Hou, Y. X. Lu, et al., “Multimorbidity of Allergic Conditions in Urban Citizens of Southern China: A Real-World Cross-Sectional Study,” Journal of Clinical Medicine 12, no. 6 (2023): 2226.

[5] M. Pinart, M. Benet, I. Annesi-Maesano, et al., “Comorbidity of Eczema, Rhinitis, and Asthma in IgE-Sensitised and Non-IgE-Sensitised Children in MeDALL: A Population-Based Cohort Study,” Lancet Respiratory Medicine 2, no. 2 (2014): 131–140.

[6] N. Ballardini, A. Bergström, C. F. Wahlgren, et al., “IgE Antibodies in Relation to Prevalence and Multimorbidity of Eczema, Asthma, and Rhinitis From Birth to Adolescence,” Allergy 71, no. 3 (2016): 342–349.

[7] J. M. Anto, J. Bousquet, M. Akdis, et al., “Mechanisms of the Development of Allergy (MeDALL): Introducing Novel Concepts in Allergy Phenotypes,” Journal of Allergy and Clinical Immunology 139, no. 2 (2017): 388–399.

[8] H. Gough, L. Grabenhenrich, A. Reich, et al., “Allergic Multimorbidity of Asthma, Rhinitis and Eczema Over 20 Years in the German Birth Cohort MAS,” Pediatric Allergy and Immunology 26, no. 5 (2015): 431–437.

[9] N. Ballardini, I. Kull, T. Lind, et al., “Development and Comorbidity of Eczema, Asthma and Rhinitis to Age 12—Data From the BAMSE Birth Cohort,” Allergy 67 (2012): 537–544.

[10] S. Hong, D. K. Son, W. R. Lim, et al., “The Prevalence of Atopic Dermatitis, Asthma, and Allergic Rhinitis and the Comorbidity of Allergic Diseases in Children,” Environmental Health and Toxicology 27 (2012): e2012006.

[11] W. Kou, X. Li, H. Yao, and P. Wei, “Meta-Analysis of the Comorbidity Rate of Allergic Rhinitis and Asthma in Chinese Children,” International Journal of Pediatric Otorhinolaryngology 107 (2018): 131–134.

[12] M. E. Wechsler, G. Scelo, D. E. S. Larenas-Linnemann, et al., “Association Between T2-Related Comorbidities and Effectiveness of Biologics in Severe Asthma,” American Journal of Respiratory and Critical Care Medicine 209, no. 3 (2024): 262–272.

[13] J. Bousquet, J. M. Anto, M. Wickman, et al., “Are Allergic Multimorbidities and IgE Polysensitization Associated With the Persistence or Re-Occurrence of Foetal Type 2 Signalling? The MeDALL Hypothesis,” Allergy 70, no. 9 (2015): 1062–1078.

[14] N. Ballardini, A. Bergström, C. F. Wahlgren, et al., “IgE Antibodies in Relation to Prevalence and Multimorbidity of Eczema, Asthma, and Rhinitis From Birth to Adolescence,” Allergy 71, no. 3 (2016): 342–349.

[15] A. H. Ziyab, “Prevalence and Risk Factors of Asthma, Rhinitis, and Eczema and Their Multimorbidity Among Young Adults in Kuwait: A Cross-Sectional Study,” BioMed Research International 2017 (2017): 2184193.

[16] Y. Shen, J. H. Zeng, S. L. Hong, and H. Y. Kang, “Prevalence of Allergic Rhinitis Comorbidity With Asthma and Asthma With Allergic Rhinitis in China: A Meta-Analysis,” Asian Pacific Journal of Allergy and Immunology 37, no. 4 (2019): 220–225.

[17] M. Hartiala, V. Elenius, A. A. Pesquera, et al., “Exposures in Indoor Air Affecting Health,” Allergy 81, no. 3 (2026): 700–719.

[18] D. Sun, L. Tang, K. Long, W. Sun, and Z. Zhang, “Bacterial Contamination in the Different Parts of Household Air Conditioners: A Comprehensive Evaluation From Chengdu, Southwest China,” Frontiers in Public Health 12 (2024): 1429626.

[19] Q. Xue, M. Zou, J. Guo, et al., “Detection and Assessment of Dust Mite Allergens in an Indoor Environment in Anhui, China”, Environmental Science and Pollution Research 30, no. 2 (2023): 3045–3055.

[20] N. Okada, Y. Shiraishi, K. Tomomatsu, T. Oguma, and K. Asano, “Moldy Odor From Air Conditioners in the Residences of Japanese Participants With and Without Asthma,” Indoor Air 32, no. 11 (2022): e13156.

[21] L. Sun, J. D. Miller, K. Van Ryswyk, et al., “Household Determinants of Biocontaminant Exposures in Canadian Homes,” Indoor Air 32, no. 1 (2022): e12933.

[22] I. Sander, A. Lotz, V. Liebers, et al., “Comparing the Concentration Levels of Allergens and Endotoxins in Employees' homes and Offices,” International Archives of Occupational and Environmental Health 95, no. 3 (2022): 573–588.

[23] X. Zhang, Y. Gao, M. Wang, L. Xi, L. Zhang, and Y. Zhang, “Trends and Clinical Features of Pet Sensitization of Allergic Rhinitis From 2017 to 2023 in Beijing, China,” International Archives of Allergy and Immunology 186, no. 8 (2025): 724–732.

[24] A. Pinot de Moira, K. Strandberg-Larsen, and T. Bishop, “Associations of Early-Life Pet Ownership With Asthma and Allergic Sensitization: A Meta-Analysis of More Than 77,000 Children From the EU Child Cohort Network,” Journal of Allergy and Clinical Immunology 150, no. 1 (2022): 82–92.

[25] J. M. Anto, J. Bousquet, M. Akdis, et al., “Mechanisms of the Development of Allergy (MeDALL): Introducing Novel Concepts in Allergy Phenotypes,” Journal of Allergy and Clinical Immunology 139, no. 2 (2017): 388–399.

[26] E. Burte, J. Bousquet, V. Siroux, J. Just, B. Jacquemin, and R. Nadif, “The Sensitization Pattern Differs According to Rhinitis and Asthma Multimorbidity in Adults: The EGEA Study,” Clinical and Experimental Allergy 47, no. 4 (2017): 520–529.

[27] V. Siroux, N. Ballardini, M. Soler, et al., “The Asthma–Rhinitis Multimorbidity Is Associated With IgE Polysensitization in Adolescents and Adults,” Allergy 73, no. 7 (2018): 1447–1458.

[28] N. Katoh, Y. Ohya, M. Ikeda, et al., “Japanese Guidelines for Atopic Dermatitis 2020,” Allergology International 69, no. 3 (2020): 356–369.

[29] H. A. Brough, A. Simpson, K. Makinson, et al., “Pea Nut Allergy: Effect of Environmental Peanut Exposure in Children With Filaggrin Loss-of Function Mutations,” Journal of Allergy and Clinical Immunology 134 (2014): 867–875.

[30] D. A. Hill and J. M. Spergel, “The Atopic March: Critical Evidence and Clinical Relevance,” Annals of Allergy, Asthma & Immunology 120 (2018): 131–137.

[31] E. M. Zoratti, R. Z. Krouse, D. C. Babineau, et al., “Asthma Phenotypes in Inner-City Children,” Journal of Allergy and Clinical Immunology 138 (2016): 1016–1029.

[32] Q. Deng and L. Liu, “One Allergy: One Exposure and One Pathway,” Pediatric Research 95, no. 7 (2024): 1683–1684.

[33] "International Study of Asthma and Allergies in Childhood," accessed November 29, 2011, http://isaac.auckland.ac.nz/phases/phasetwo/phasetwomodules.pdf .

[34] "GINA Executive and Science Committee: Global Strategy for Asthma Management and Prevention," accessed May 8, 2007, http://www.ginasthma.com/Guidelineitem.

[35] J. Bousquet, P. Van Cauwenberge, and N. Khaltaev, “Allergic Rhinitis and Its Impact on Asthma,” Journal of Allergy and Clinical Immunology 108 (2001): S147–S334.

[36] T. Zuberbier, W. Aberer, and R. Asero, “The EAACI/GA²LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria,” Allergy 73, no. 7 (2018): 1393–1414.

[37] G. Roberts, O. Pfaar, and C. Akdis, “EAACI Guidelines on Allergen Immunotherapy: Allergic Rhinoconjunctivitis,” Allergy 73, no. 4 (2018): 765–798.

RIGHTS & PERMISSIONS

2026 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.